Rapid rise in serum thyrotropin concentrations after thyroidectomy or withdrawal of suppressive thyroxine therapy in preparation for radioactive iodine administration to patients with differentiated thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 7, 2004, Pages 3285-3289

  Serhal, Dina I ^a   Nasrallah, Mona P ^a   Arafah, Baha M ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; HUMAN; HYPOTHYROIDISM; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL PARAMETERS; THYROID CANCER; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TREATMENT WITHDRAWAL;

ADULT; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; POSTOPERATIVE PERIOD; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; THYROXINE; TIME FACTORS; TRIIODOTHYRONINE;

ENTEROBACTERIA PHAGE T4;

EID: 3242683992     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031139     Document Type: Article

References (18)

1. Mazzaferri EL, Jhiang SM 1994 Long term impact of initial surgery and medical therapy in papillary and follicular thyroid cancer. Am J Med 97:418-428
2. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG 1992 The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714-720
3. Meier CA, Braverman LE, Ebner S, Veronikis I, Daniels GH, Ross DS, Deraska DJ, Davies TF, Valentine M, DeGroot LJ 1994 Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). J Clin Endocrinol Metab 78:188-196
4. Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham KE, Braverman LE, Skarulis MC, Davies TF, DeGroot LJ, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Becker DV, Maxon 3rd HR, Cavalieri RR, Spencer CA, McEllin K, Weintraub BD, Ridgway EC 1999 A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84:3877-3885
5. Stahl TJ, Shapiro B 1973 Use of human thyrotropin radioimmunoassay in the management of patients with thyroid carcinoma. J Nucl Med 14:900-902
6. Varma VM, Beirwaltes WH 1970 Treatment of thyroid cancer. JAMA 214: 1437-1442
7. 3 withdrawal or thyroidectomy in the therapy of thyroid carcinomas. J Nucl Med 20:928-932
8. Ain KB 2002 Thyroid cancer. In: Rakel RE, Bope ET, eds. Conn's current therapy. Philadelphia: WB Saunders; 652-657
9. Mazzaferri EL 2000 Radioiodine and other treatments and outcomes. In: Braverman LE, Utiger RD, Ingbar SH, Werner SC. Werner and Ingbar's the thyroid: a fundamental and clinical textbook, 8th ed. Philadelphia: Lippincott-Williams, Wilkins; 904-929
10. Cotton GE, Gorman CA, Mayberry WE 1971 Suppression of thyrotropin (h-TSH) in serums of patients with myxedema of varying etiology treated with thyroid hormones. N Engl J Med 285:529-533
11. 131I uptake postthyroidectomy for thyroid cancer. J Clin Endocrinol Metab 50:734-739
12. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306
13. Tamai H, Suemastu H, Kurokawa N, Esaki M, Ikemi T, Matsuzuka F, Kuma K, Nagataki S 1979 Alterations in circulating thyroid hormones and thyrotropin after complete thyroidectomy. J Clin Endocrinol Metab 48:54-58
14. Liel Y 2002 Preparation for radioactive iodine administration in differentiated thyroid cancer patients. Clin Endocrinol (Oxf) 57:523-527
15. 131I scintiscans and thyroglobulin testing. Thyroid 6:69-73
16. Edmonds CJ, Hayes S 1977 Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine. Br J Radiol 50:799-807
17. Vagenakis AG, Braverman LE, Azizi F, Portnay GI, Ingbar SH 1975 Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy. N Engl J Med 293:681-684
18. Bunneister LA, Goumaz MO, Mariash CW, Oppenheimer JH 1992 Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 75:344-350